Vioxx Plaintiffs Take $5B Deal Woes To High Court
A group of plaintiffs challenging Merck & Co. Inc.'s $4.85 billion settlement of multidistrict litigation over its painkiller Vioxx has asked the U.S. Supreme Court to consider whether the mass settlement...To view the full article, register now.
Already a subscriber? Click here to view full article